CONGRESS 2023 - New drugs for bad bugs: What’s in the pipeline?

Increasing antimicrobial resistance observed globally in key Gram-negative bacteria and failure of the antimicrobial development pipeline to keep up has left clinicians with few remaining treatment options. This presentation will: i) highlight the current gaps in our antimicrobial armamentarium (with a focus on the World Health Organisation critical priority pathogens); ii) give an overview of new antimicrobials that have reached phase 3 clinical trials and other therapeutic approaches currently in the pipeline; and iii) share experience from the reference laboratory.

Download as vCalendar (for Microsoft Outlook etc.)

Import event to your Google Calendar